| mRNA |
Ko-143 |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
SB590885 |
GDSC1000 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
| mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
| mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
-0.002 |
0.9 |
| mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
| mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
0.9 |
| mRNA |
PHA-793887 |
GDSC1000 |
pan-cancer |
AAC |
-0.0018 |
0.9 |
| mRNA |
T0901317 |
GDSC1000 |
pan-cancer |
AAC |
0.0021 |
1 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0021 |
1 |